Owlet, Inc.

Owlet, Inc.OWLTEarnings & Financial Report

NYSE · Health Care · Measuring & Controlling Devices, NEC

Owlet, Inc. is a pediatric health technology firm that develops smart wearable monitoring products for infants, most notably its signature smart sock that tracks real-time heart rate, oxygen levels, and sleep metrics. It serves global consumer markets across North America, Europe, and Asia-Pacific, distributing products via direct-to-consumer e-commerce and partnered retail outlets, focused on supporting parental peace of mind and infant health safety.

Revenue

$14.8M

Gross Profit

$6.5M

Operating Profit

$-5.7M

Net Profit

$3.3M

Gross Margin

44.4%

Operating Margin

-39.0%

Net Margin

22.2%

YoY Growth

37.4%

EPS

$-0.51

Owlet, Inc. Q1 FY2024 Financial Summary

Owlet, Inc. reported revenue of $14.8M (up 37.4% YoY) for Q1 FY2024, with a net profit of $3.3M (up 127.6% YoY) (22.2% margin). Cost of goods sold was $8.2M, operating expenses totaled $12.3M.

Key Financial Metrics

Total Revenue$14.8M
Net Profit$3.3M
Gross Margin44.4%
Operating Margin-39.0%
Report PeriodQ1 FY2024

Revenue Breakdown

Owlet, Inc. Q1 FY2024 revenue of $14.8M breaks down across 2 segments, led by US at $12.9M (87.5% of total).

SegmentRevenue% of Total
US$12.9M87.5%
Non Us$1.8M12.5%

Owlet, Inc. Revenue by Segment — Quarterly Trend

Owlet, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as US and Non Us) has evolved quarter over quarter.

SegmentQ4 FY2025Q3 FY2025Q2 FY2025Q1 FY2025
US$22.7M$24.2M
Non Us$3.2M$1.1M

Owlet, Inc. Annual Revenue by Year

Owlet, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $105.7M).

YearAnnual Revenue
2025$105.7M
2024$78.1M
2023$54.0M
2022$69.2M

Owlet, Inc. Quarterly Revenue & Net Profit History

Owlet, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q4 FY2025$26.6M+29.6%$-9.2M-34.6%
Q3 FY2025$32.0M+44.6%$4.1M12.9%
Q2 FY2025$26.1M+25.9%$-37.6M-144.4%
Q1 FY2025$21.1M+43.1%$3.0M14.3%
Q4 FY2024$20.5M-2.5%$-9.1M-44.2%
Q3 FY2024$22.1M+140.9%$-5.6M-25.4%
Q2 FY2024$20.7M+58.2%$-1.1M-5.5%
Q1 FY2024$14.8M+37.4%$3.3M22.2%

Income Statement

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Revenue$14.8M$20.7M$22.1M$20.5M$21.1M$26.1M$32.0M$26.6M
YoY Growth37.4%58.2%140.9%-2.5%43.1%25.9%44.6%29.6%

Balance Sheet

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Assets$43.8M$45.9M$56.1M$49.5M$51.4M$63.5M$74.9M$85.6M
Liabilities$65.6M$66.7M$65.5M$66.3M$63.4M$108.0M$113.5M$50.2M
Equity$-32.9M$-33.4M$-21.5M$-29.8M$-25.8M$-59.2M$-54.1M$19.0M

Cash Flow

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Operating CF$-3.4M$-3.4M$-7.5M$3.0M$-5.9M$-2.2M$-2.2M$-452000